Search results
Results from the WOW.Com Content Network
The first DOS version of MedCalc was released in April 1993 and the first version for Windows was available in November 1996. Version 15.2 introduced a user-interface in English, Chinese (simplified and traditional), French, German, Italian, Japanese, Korean, Polish, Portuguese (Brazilian), Russian and Spanish.
Lincoln Pharmaceuticals was established in 1979 in Ahmedabad, Gujarat by Mr. Mahendra G Patel, Rajnikant G Patel, and Hasmukhbhai I Patel. [7] In the year 1996, Lincoln Pharma launched IPO and was listed on Bombay Stock Exchange. By the year 2000, the company's products were available in 80% of the domestic market across India.
The Gujarat government has also established several science and technology parks in the state, including the Gujarat Science City in Ahmedabad [44] and the Gujarat Biotech Park in Vadodara. These parks provide infrastructure and support services to companies engaged in R&D activities in various sectors, including pharmaceuticals.
Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta , initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals – One of the largest pharmaceutical companies of India. It has four manufacturing plants: (a) Chhatral, Gujarat and (b) Baddi, Himachal Pradesh c) Gangtok Sikkim and d) Dahej, Gujarat. It has a research centre at Bhat, near Ahmedabad in Gujarat.
MDCalc is a free online medical reference for healthcare professionals that provides point-of-care clinical decision-support tools, including medical calculators, scoring systems, and algorithms. [1]
Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. [2] It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. [3] It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. [1]
Cadila Pharmaceuticals has established a dedicated R&D facility, spread over 105,000 sq. ft. area at Dholka, Gujarat, India which is staffed by 300 scientists. [citation needed] The company has five IND dossiers filed with the USFDA for pulmonary tuberculosis, lung cancer, prostate cancer, bladder cancer and melanoma.